ESR1 and breast carcinoma: In the clinical database results, we checked the high expression of FOXA1 in only the hormone-receptor-positive breast cancer (HR+ BC) subtype and the worse overall survival for high FOXA1 gene expression in ER + /PR+ breast cancer patients.